alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exibit 4.38

TERMINATION AGREEMENT


This TERMINATION AGREEMENT (this "Agreement") is dated as of 31st March 2016 and entered into by and between:


(1)          OCEAN RIG MANAGEMENT INC. a company organized and existing under the laws of Marshall Islands with registered address at Trust Company Complex, Ajeltake Road, Ajeltake Island, Majuro, Marshall Islands MH96960 (the "OR Management"); and


(2)          VIVID FINANCE LIMITED, a company organized and existing under the laws of Cyprus having its registered office at 10 Skopa Street, Nicosia, Cyprus ("Vivid")


(collectively referred to as "Parties", and individually as "Party")


WHEREAS:



	A.	
OR Management and Vivid have entered into a Consultancy Agreement with effect as of 1st January 2013, as amended from time to time (the "Consultancy Agreement") pursuant to which Vivid was engaged to act as consultant on matters of financing for OR Management and Ocean Rig UDW Inc. of Cayman Islands ("UDW") and for any affiliates, subsidiaries or holding companies thereof, as directed by OR Management and Vivid was entitled to receive from OR Management the fees referred therein.








	B.	
The Parties have mutually agreed to terminate at no cost the Consultancy Agreement with effect as of 31st March 2016.







NOW THEREFORE the Parties hereto agree as follows:



	1.	
THAT the Consultancy Agreement shall be terminated at no cost and shall be no longer in force and effect with effect as of 31st March 2016 (the "Effective Date").








	2.	
THAT from the Effective Date the Parties hereby mutually release and discharge each other and any of its affiliates, subsidiaries or holding companies and its officers, directors and employees from and against any and all monetary claims, costs, damages, liabilities, and/or any other debts whatsoever which either of the Parties hereto now has or may hereafter have, against the other Party hereto, by reason of, or in connection with the Consultancy Agreement and/or the termination of the Consultancy Agreement pursuant to the provisions of this Agreement.







IN WITNESS WHEREOF the Parties hereto have executed this Agreement as of the date first above written.


(Signature page to follow.)
















	
For and on behalf of


OCEAN RIG MANAGEMENT INC.


 


 


 


/s/ Adriano Cefai                                            


Name: Dr. Adriano Cefai

 Title: Director of OMEGA SERVICES


LIMITED, Sole Director of Ocean Rig

 Management Inc.


 


Dr. Adriano Cefai

Director

Omega Services Limited

5/1 Merchants Street

 Valletta VLT 1171

	
For and on behalf of


VIVID FINANCE LIMITED


 


 


 


/s/ Yiannoula Georghiades        

Name: Yiannoula Georghiades

 Title: Director


 


 


 


/s/ Eleni Papapetrou                    


Eleni Papapetrou

 Title: Director
#### Israel HIDALGO, Petitioner-Appellant, v. UNITED STATES of America; Dan Dove, Warden Federal Correctional Institution Edgefield, Respondents-Appellees.

No. 02-7898.

United States Court of Appeals, Fourth Circuit.

Submitted Jan. 30, 2003.

Decided Feb. 5, 2003.

*641Israel Hidalgo, Appellant Pro Se.

Before WIDENER, NIEMEYER, and TRAXLER, Circuit Judges.

Affirmed by unpublished PER CURIAM opinion.

PER CURIAM.

Israel Hidalgo, a federal prisoner, appeals the district court’s order accepting the recommendation of the magistrate judge and dismissing his petition filed under 28 U.S.C. § 2241 (2000). We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. *See Hi-dalgo v. United States,*No. CA-02-2242 (D.S.C. Nov. 21, 2002). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED.*
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 370 Introduced in Senate (IS)]

104th CONGRESS
  1st Session
                                 S. 370

     To provide guidelines for the membership of committees making 
  recommendations on the rules of procedure appointed by the Judicial 
                  Conference, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

             February 8 (legislative day, January 30), 1995

  Mr. Heflin introduced the following bill; which was read twice and 
               referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
     To provide guidelines for the membership of committees making 
  recommendations on the rules of procedure appointed by the Judicial 
                  Conference, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MEMBERSHIP OF COMMITTEES MAKING RECOMMENDATIONS ON RULES OF 
              PROCEDURE.

    Section 2073(a)(2) of title 28, United States Code, is amended by 
striking out the second sentence and inserting in lieu thereof ``Each 
such committee shall have a majority of members of the practicing bar, 
and also shall have members of the bench (including trial and appellate 
judges) and academics.''.
                                 <all>
```
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS OF FILM ROMAN, INC., AS OF AND FOR THE YEAR
ENDED DECEMBER 31, 1996, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                      13,738,927
<SECURITIES>                                         0
<RECEIVABLES>                                6,956,409
<ALLOWANCES>                                         0
<INVENTORY>                                 21,268,945
<CURRENT-ASSETS>                                     0
<PP&E>                                       1,471,581
<DEPRECIATION>                                 934,192
<TOTAL-ASSETS>                              42,817,295
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        84,498
<OTHER-SE>                                  23,702,755
<TOTAL-LIABILITY-AND-EQUITY>                42,817,295
<SALES>                                     49,697,655
<TOTAL-REVENUES>                            49,697,655
<CGS>                                       50,778,748
<TOTAL-COSTS>                               50,778,748
<OTHER-EXPENSES>                             3,849,864
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             297,933
<INCOME-PRETAX>                            (4,633,024)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (4,633,024)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (4,633,024)
<EPS-PRIMARY>                                   (1.63)
<EPS-DILUTED>                                        0


</TABLE>
<PAGE>

EXHIBIT 21.  SUBSIDIARIES OF THE REGISTRANT


Name of Subsidiary                                     State of Incorporation
American Health Services Corp.                         Delaware
     Radiosurgery Centers, Inc.                        Delaware

Maxum Health Corp.                                     Delaware
     MTS Enterprises, Inc.                             Texas
     Quest Financial Services Inc.                     Delaware
     Maxum Health Services Corp.                       Delaware
          DiagnosTemps, Inc.                           Delaware
          Maxum Health Management Corp.                Delaware
          Maxum Health Services of North Texas, Inc.   Texas
          Maxum Health Services of Arlington, Inc.     Texas
          Maxum Health Services of Dallas, Inc.        Texas
          North Dallas Diagnostic Center, Inc.         Texas

Open MRI, Inc.                                         Delaware
11TH COURT OF APPEALS

EASTLAND, TEXAS

JUDGMENT

Toni Macaluso Cichy, * From the 142nd District

 Court of Midland County,

 Trial Court No. CR40041.

Vs. No. 11-13-00366-CR * November 12, 2015

The State of Texas, * Memorandum Opinion by Wright, C.J.

 (Panel consists of: Wright, C.J.,

 Willson, J., and Bailey, J.)

This court has inspected the record in this cause and concludes that 

there is no error in the judgment below. Therefore, in accordance with this 

court’s opinion, the judgment of the trial court is in all things affirmed.
<PAGE>
                                                                   EXHIBIT 24.11



                               POWER OF ATTORNEY


The undersigned director and/or officer of Karrington Health, Inc. (the
"Company"), does hereby constitute and appoint Richard R. Slager and Thomas
J. Klimback, or either of them, my true and lawful attorneys and agents, each
with full power of substitution, to do any and all acts and things in my name
and on my behalf in my capacity as a director of the Company and to execute
any and all instruments for me and in my name in the capacity indicated
above, which said attorneys or agents, or either of them, may deem necessary
or advisable to enable the Company to comply with the Securities Exchange Act
of 1934, as amended, and any rules, regulations and requirements of the
Securities and Exchange Commission thereunder, in connection with the filing
requirements of the Company's Annual Report on Form 10-K for the fiscal year
ended December 31, 1997 (the "1997 Form 10-K"), including specifically but
without limitation, power and authority to sign for me in my name, in the
capacity indicated above, the 1997 Form 10-K and any and all amendments to
such 1997 Form 10-K; and I do hereby ratify and confirm all that the said
attorneys and agents, or their substitute or substitutes, or either of them,
shall do or cause to be done by virtue hereof.

                                        /s/ HAROLD A. POLING
                                        Harold A. Poling
                                        Director
<TABLE> <S> <C>

<ARTICLE> 9
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                             769
<INT-BEARING-DEPOSITS>                           5,444
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     50,109
<INVESTMENTS-CARRYING>                          47,840
<INVESTMENTS-MARKET>                            47,553
<LOANS>                                         66,679
<ALLOWANCE>                                      (500)
<TOTAL-ASSETS>                                 178,194
<DEPOSITS>                                     128,852
<SHORT-TERM>                                     5,000
<LIABILITIES-OTHER>                              1,886
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            27
<OTHER-SE>                                      42,430
<TOTAL-LIABILITIES-AND-EQUITY>                 178,194
<INTEREST-LOAN>                                  5,398
<INTEREST-INVEST>                                5,499
<INTEREST-OTHER>                                   438
<INTEREST-TOTAL>                                11,335
<INTEREST-DEPOSIT>                               6,202
<INTEREST-EXPENSE>                               6,319
<INTEREST-INCOME-NET>                            5,016
<LOAN-LOSSES>                                        0
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  3,718
<INCOME-PRETAX>                                  1,604
<INCOME-PRE-EXTRAORDINARY>                       1,604
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,061
<EPS-PRIMARY>                                      .15
<EPS-DILUTED>                                      .15
<YIELD-ACTUAL>                                    7.20
<LOANS-NON>                                        299
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                   573
<CHARGE-OFFS>                                       73
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                  500
<ALLOWANCE-DOMESTIC>                                 0
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                            500
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE>                              5

<S>                                             <C>
<PERIOD-TYPE>                                      6-MOS
<FISCAL-YEAR-END>                               DEC-31-2000
<PERIOD-START>                                  JAN-01-2000
<PERIOD-END>                                    JUN-30-2000
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                       0
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         2,000
<OTHER-SE>                                      (2,000)
<TOTAL-LIABILITY-AND-EQUITY>                         0
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0



</TABLE>
1

Daniels, Nia (FAA)

From: Miller, Jeff <jmiller@airlines.org>

Sent: Monday, May 23, 2016 2:15 PM

To: Daniels, Nia (FAA)

Cc: Thompson, Mary (FAA); Rowe, Salli M (FAA); Roberts, Brandon (FAA); Ferritto, Michelle 

(FAA); Mullen, Doug; Ghezai, Sophia

Subject: RE: Petition for Exemption: Airlines for America (Docket No. FAA-2002-12455)

Ms. Daniels, 

Thanks for the information and the clarification over the telephone. 

In order to expedite the issuance of the exemption (5487K), we withdraw the request for the amendment that was 

discussed in the initial exemption 5487K extension request (dated Feb 4, 2014). 

We will resubmit the amendment request after the extension has been issued. 

Since your email below states that we can make this request through a simple email reply, we will not submit any 

documentation to the docket (FAA-2002-12455) at this time. 

Thanks 

Jeff Miller 

Jeffrey A. Miller

Managing Director, Flight Operations

Airlines for America

We Connect the World

Office: 202.626.4285 

Mobile: 407-758-1235

airlines.org | Facebook | Twitter | Instagram | LinkedIn

From: Nia.Daniels@faa.gov [mailto:Nia.Daniels@faa.gov] 

Sent: Monday, May 23, 2016 1:21 PM 

To: Miller, Jeff 

Cc: Mary.Thompson@faa.gov; salli.m.rowe@faa.gov; Brandon.Roberts@faa.gov; Michelle.Ferritto@faa.gov

Subject: Petition for Exemption: Airlines for America (Docket No. FAA-2002-12455) 

Mr. Miller,  

On March 2, 2016, your petition for an exemption posted to the docket. We have received your petition request on

behalf of Airlines for America, which asks for an extension to your current exemption 5487K and an amendment. The

amendment you request would allow you to issue a temporary confirmation document in either paper or electronic

form to crewmembers who do not have their airmen or medical certificate in their personal possession.  

As you know, your current extension expires July 31, 2016. However, in order to expedite the issuance of your extension,

we respectfully ask that you withdraw your request for the amendment and resubmit it after the extension has been

issued. Because the amendment would be precedent setting and would likely result in new conditions and limitations,

we need additional time to make a determination and complete legal review. We do not want the existing exemption to

lapse in the meantime.  

You can submit the clarification by going to your docket at www.regulations.gov (Docket No. FAA‐2002‐12455) or by

replying to this email.  

If you have any questions or concerns, my contact information is below.
2

Thank you,  

Nia Daniels, ARM‐108

Federal Aviation Administration

Office of Rulemaking, Airmen & Airspace Rules Division

800 Independence Avenue, SW

Washington, DC 20591

PH: (202) 267 ‐ 7626

Fax: (202) 267 ‐ 5075

nia.daniels@faa.gov
[Federal Register Volume 89, Number 27 (Thursday, February 8, 2024)]
[Notices]
[Page 8729]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02531]


-----------------------------------------------------------------------

POSTAL SERVICE


Product Change--Priority Mail and USPS Ground Advantage[supreg] 
Negotiated Service Agreement

AGENCY: Postal Service<SUP>TM</SUP>.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Postal Service gives notice of filing a request with the 
Postal Regulatory Commission to add a domestic shipping services 
contract to the list of Negotiated Service Agreements in the Mail 
Classification Schedule's Competitive Products List.

DATES: Date of required notice: February 8, 2024.

FOR FURTHER INFORMATION CONTACT: Sean Robinson, 202-268-8405.

SUPPLEMENTARY INFORMATION: The United States Postal Service[supreg] 
hereby gives notice that, pursuant to 39 U.S.C. 3642 and 3632(b)(3), on 
February 1, 2024, it filed with the Postal Regulatory Commission a USPS 
Request to Add Priority Mail & USPS Ground Advantage[supreg] Contract 
181 to Competitive Product List. Documents are available at 
www.prc.gov, Docket Nos. MC2024-178, CP2024-184.

Sean Robinson,
Attorney, Corporate and Postal Business Law.
[FR Doc. 2024-02531 Filed 2-7-24; 8:45 am]
BILLING CODE 7710-12-P
EXHIBIT 32.2

CERTIFICATION

In connection with the Annual Report
of Endologix, Inc. (the Company) on Form 10-K for the fiscal year ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Robert J. Krist, Chief Financial Officer
of the Company, certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)) and 18 U.S.C. Section 1350, that to the best of my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.



/s/ Robert J. KristRobert J. KristChief Financial Officer


This
certification accompanies this Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the
Securities Exchange Act of 1934.

Date: March 5, 2010
II

104TH CONGRESS

1ST SESSION S. 572

To expand the authority for the export of devices, and for other purposes.

IN THE SENATE OF THE UNITED STATES

MARCH 16, 1995

Mr. COATS introduced the following bill; which was read twice and referred

to the Committee on Labor and Human Resources

A BILL

To expand the authority for the export of devices, and for

other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Medical Device Expor5 tation Act of 1995’’.

6 SEC. 2 AUTHORITY.

7 (a) EXPORTATION OF DEVICES.—

8 (1) IN GENERAL.—In the administration of sec9 tion 801(e)(2) of the Federal Food, Drug, and Cos10 metic Act (21 U.S.C. 381(e)(2)), the Secretary of

11 Health and Human Services shall make the deter-
2

•S 572 IS

1 mination under such section, on the basis of a notice

2 described in paragraph (2) with respect to a medical

3 device, that the exportation of the device is not con4 trary to public health and safety and has the ap5 proval of the country to which the device is intended

6 for export.

7 (2) NOTICE REQUIREMENT.—A determination

8 made under paragraph (1) shall be based on either

9 of the following notices:

10 (A) Notice to the Secretary by the export11 ing company of approval for marketing or in12 vestigational use of the device in the European

13 Community (such approval for marketing re14 ferred to as the ‘‘CE’’ mark).

15 (B) Notice to the Secretary by the export16 ing company of approval for marketing or in17 vestigational use of the device by the Ministry

18 of Health and Welfare of Japan or by another

19 appropriate body in the government of Japan.

20 (b) APPLICABILITY.—

21 (1) INVESTIGATIONAL USE.—In a case of a de22 vice approved only for investigational use, subsection

23 (a) shall not apply unless the initial country of des24 tination has also approved the device for investiga25 tional use.
3

•S 572 IS

1 (2) BANNED DEVICE.—Subsection (a) shall not

2 apply to any device that has been banned by the

3 Secretary of Health and Human Services under sec4 tion 516 of the Federal Food, Drug, and Cosmetic

5 Act (21 U.S.C. 360f).

Æ
**EXHIBIT 23.1**

 

**CONSENT OF INDEPENDENT AUDITORS**

 

We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-91525, 333-59253 and 333-89884) pertaining toThe SCPIE Holdings Inc. Employee Stock Purchase Plan and the 2001 Amended and Restated Equity Participation Plan of SCPIE Holdings Inc., as amended, respectively, of our report dated March 14, 2005, with respect to the consolidated financialstatements and schedules included in its Annual Report (Form 10-K) for the year ended December 31, 2004. 

 

Los Angeles, California 

March 16, 2005